to join the discussion
SYG sitting at R33.00 and the rand's been getting smacked which usually helps exporters but med device play like this is mostly local exposure so that's not really a tailwind. What matters is whether they can grow earnings off a higher base once load-shedding stops kneecapping hospital capex, that's the real story. Long-term view hasn't changed, just waiting for margins to actually improve when input costs normalise.
SYG sitting at R33.00 and honestly the medical device play still makes sense long term, eish just wish they'd show some proper revenue growth. Africa's got massive healthcare gaps and someone's gotta fill them, might as well be local hey.
SYG sitting at R33.00 and the medical device space locally is still underpenetrated compared to what it should be. Balance sheet is solid enough to weather the rand weakness without getting crushed on imports. Good day to top up if you believe in the healthcare shift post covid, not many pure play med device stocks on the JSE worth a look.
SYG's up 2.29% today but the rally feels thin given their AUM growth has stalled and fee pressure is real in this market. I reckon the Street's being too generous on valuation here - wouldn't chase it at these levels.
SYG down nearly 5% today. Is this a knee-jerk reaction to market sentiment or are there actual headwinds in the wealth management space we should be watching? Curious what the dividend story looks like at these levels given the pullback.
Sygnia at R3259 is trading flat today, but the real question is whether this wealth management and healthcare admin play can capture meaningful market share as the private healthcare ecosystem consolidates. With structural tailwinds from middle-class growth and the government's c
SYG taking a small knock at R3259 today but the asset management angle doesn't excite me the way agricultural plays do. Compare this to something like Mediclinic which at least has actual healthcare delivery exposure and patient revenue streams. The wealth management space feels
SYG climbing 3% today to R3329 got me thinking: are we pricing in genuine operational leverage from their asset management division, or just riding sentiment off the broader healthcare rally. The dividend yield sits around 2.8% which feels modest compared to my property rental re
SYG up 1.72% today at R3199, but it's still trading at a hefty P/E compared to the broader financials and healthcare space. Like choosing between breeding Merino and Angora sheep, you're paying premium prices here and need to believe the wool quality justifies it.
SYG dropping 1.11% today but I'm looking at their asset management side. With all these ETFs and retirement funds becoming popular in SA, Sygnia's got real growth potential if they can capture more of that market.
SYG down 2.32% today but the asset manager's valuation still looks reasonable for a business with consistent fee-generating income streams, though I'd want to see how net inflows hold up if equity markets remain volatile during this warm, dry spell we're experiencing. Healthcare
SYG at R3094 is consolidating after that brutal selloff in healthcare equities, but the long-term thesis remains intact for a wealth manager with genuine offshore diversification credentials and a growing institutional base. The sector's valuation compression created the exact op
Took a small trimming position in SYG today after that dip to R3061, though I'll admit healthcare plays sit outside my usual groceries wheelhouse and the fund management space feels crowded with fee pressure these days.
SYG down 1.19% today but I'm not losing sleep over daily noise in the healthcare space. The real question is whether their asset management division can weather the next rate cycle without margin compression, especially if medical inflation keeps outpacing wage growth in the sect
SYG at R3087 after that 1.35% bump - is anyone else seeing the healthcare yield squeeze tightening, or are the distributions still justifying the entry point here?
SYG at R3100 up 1.81% today - is this healthcare fund actually catching real inflows or just tracking the broader recovery? The dividend yield looks decent but I'm wondering if the portfolio's exposure to private clinics is holding up with this economic backdrop.
SYG down 1.58% to R2990 — healthcare income funds under pressure as bond yields climb. At these levels, the distribution yield becomes more attractive, but you're paying premium valuations for defensive cash flows in a rising rate environment.
SYG at R3110 jumping 3.67% today, but I'm watching if this healthcare income play can sustain distributions when bond yields keep shifting. Long term, the recurring nature of medical scheme payouts appeals to me for the kids' fund, just need to see if they navigate rate cycles wi